Month: June 2021

TORONTO, June 10, 2021 (GLOBE NEWSWIRE) — Hanna Capital Corp. (the “Corporation”), a publicly traded company focused on raising capital for exploration mainly in the base metal and resource sectors to provide investors with long-term capital growth by investing in a portfolio of undervalued companies and assets, is pleased to announce that Mr. John Gould has been appointed as the Corporation’s new Chief Executive Officer. Mr. Gould holds a B.Sc. degree from the University of Witwatersrand and a B.Sc. (Hons) from the University of the North-West. At the start of Mr. Gould’s career, he was initially involved in Witwatersrand and Bushveld-type mining operations in South Africa. His experience includes all aspects of mining and geological that extended over deep and shallow level gold mining operations (Venterspost, East Driefontein,...

MALVERN, Pa., June 10, 2021 (GLOBE NEWSWIRE) — Baudax Bio, Inc. (NASDAQ:BXRX), a pharmaceutical company focused on developing and commercializing innovative products for acute care settings, today announced Gerri Henwood, the Company’s President and Chief Executive Officer, will participate in a fireside chat virtually at the JMP Securities Life Sciences Conference on Thursday, June 17, 2021 at 4:00 p.m. ET. A live webcast of the fireside chat will be available on the “Presentations” page within the investors section of the Baudax Bio website at https://www.baudaxbio.com/news-and-investors. A replay will be available on the Baudax Bio website for a period of 30 days following the event. About Baudax Bio Baudax Bio is a pharmaceutical company focused on developing and commercializing innovative products for acute care settings....

DALLAS, June 10, 2021 (GLOBE NEWSWIRE) — Rapid Therapeutic Science Laboratories, Inc. (OTC Pink: RTSL), an SEC fully-reporting, growth-oriented aerosol manufacturing company focused on delivery of non-psychoactive cannabinoid compounds, announced today that it has concluded lab development on three (3) formulas related to manufacturing of pharmaceutical grade isolates used in both metered dose inhalers and other aerosol products. RTSL has developed three (3) proprietary pharmaceutical formulas, two (2) for cannabidiol (CBD) and one (1) for cannabigerol (CBG), to initially be used in Metered Dose Inhalers (MDI). One CBD formula is expected to be used in testing of the MDI which the Company plans to submit to the U.S. Food and Drug Administration (FDA) in connection with an Investigational New Drug Application (IND), as previously...

– Data further supports plinabulin’s fast onset of action and CIN prevention benefit in week 1 following chemotherapy – Single agent plinabulin (day 1 dose as chemotherapy), had non-inferior protection against CIN compared to pegfilgrastim (day 2 dose), while performing numerically better for reduction of febrile neutropenia and chemo dose delay, with significantly lower bone pain NEW YORK, June 10, 2021 (GLOBE NEWSWIRE) — BeyondSpring Inc. (the “Company” or “BeyondSpring”) (NASDAQ: BYSI), a global biopharmaceutical company focused on the development of innovative cancer therapies, today announced presentation of data from the PROTECTIVE-1 Phase 3 clinical study of plinabulin for prevention of chemotherapy-induced neutropenia (CIN) at the American Society of Clinical Oncology (ASCO) Annual Meeting being held on June...

VANCOUVER, British Columbia, June 10, 2021 (GLOBE NEWSWIRE) — BC Craft Supply Co. Ltd., (CSE: CRFT) (“CRFT” or the “Company”), a diversified wellness company advancing cannabinoid and psychedelic innovation and psychotherapy, is pleased to announce the launch of Grizzlers™, its flagship legacy cannabis brand into the markets of Ontario and Alberta. Grizzlers™ is a legacy brand of pre-rolled craft cannabis; offering access to premium grown, hang dried, hand trimmed, and hand packed cannabis at accessible prices. Since its inception in 2017, Grizzlers™ quickly grew to be the most widely available legacy pre-roll producer in the country; achieving national distribution and wide-scale brand recognition. Fueled by significant market anticipation, Grizzlers™ is launching two SKUs: a 7 x 0.5g (multi-pack) format and a 0.5g (single-serve)...

MannKind will conduct formulation and preclinical studies of a new chemical entity owned by Thirona In addition, MannKind purchased a convertible note issued by Thirona WESTLAKE VILLAGE, Calif. and SAN DIEGO, June 10, 2021 (GLOBE NEWSWIRE) — MannKind Corporation (Nasdaq: MNKD) and Thirona Bio, Inc. today announced that they have entered into a transaction that is intended to advance the development of a novel compound with potential for multiple indications. FBM5712 is a novel small molecule inhibitor of the ALK-5 kinase (the transforming growth factor-β (TGF-β) receptor kinase), which is being developed by Thirona as a topical product intended to prevent and/or reduce skin fibrosis.  “TGF-β is also implicated in lung fibrotic diseases and ALK-5 has been validated as a potential target for idiopathic pulmonary fibrosis,” said Thomas...

Now eligible to conduct business with the US Government. SAN DIEGO, June 10, 2021 (GLOBE NEWSWIRE) — GBT Technologies Inc. (OTC PINK: GTCH) (“GBT”, or the “Company”) received an activation noticed for its System for Award Management (SAM) registration #832011626/91FW3. The active status makes GBT eligible to conduct business with the US government contractors and/or sub-contractors. A SAM registration is required for entities to conduct business with federal government agencies, contractors/subcontractors, local cities or to receive federal funds. The SAM (www.sam.gov) is a central registration system for government contractors and suppliers. GBT has filed an application with GSA (General Services Administration) to get approved to sell to the United States Government and SAM is one of the stages required. To become eligible...

Long Beach, Calif., June 10, 2021 (GLOBE NEWSWIRE) — Molina Healthcare, Inc. (NYSE: MOH) today announced details for the release of its results for the second quarter ended June 30, 2021. Molina Healthcare will issue its earnings release for the second quarter 2021 after the market closes on Wednesday, July 28, 2021, and will host a conference call and webcast to discuss the earnings release on Thursday, July 29, 2021, at 8:00 a.m. Eastern Time. To access this interactive teleconference, dial (877) 883-0383 and enter the confirmation number, 5686734. A telephonic replay of the conference call will be available through Thursday, August 12, 2021, by dialing (877) 344-7529 and entering the confirmation number, 10157375. A live broadcast of Molina Healthcare’s conference call will be available on the Company’s website, molinahealthcare.com....